Publications scientifiques

Depuis le 06/11/2023

  1. Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
    de Germay S, Singier A, Salvo F, Pariente A; French Pharmacovigilance Network.
    Drug Saf. 2023
  2. Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase.
    Calapai F, Mannucci C, McQuain L, Salvo F.
    Pharmaceuticals (Basel). 2023
  3. Analgesic switching in chronic users of dextropropoxyphene in France.
    Daveluy A, Bryan MC, Miremont-Salamé G, Lassalle R, Lacueille C, Grelaud A, Floccia M, Haramburu F, Lapeyre-Mestre M, Micallef J, Salvo F.
    Fundam Clin Pharmacol. 2023
  4. Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting.
    Maumus-Robert S, Jarne-Munoz A, Pariente A, Duroux T, Duranteau L, Bezin J.
    Front Endocrinol (Lausanne). 2023
  5. Factors associated with internal contamination of nurses by antineoplastic drugs based on biomonitoring data from a previous study.
    Villa A, Geshkovska A, Bellagamba G, Baldi I, Molimard M, Verdun-Esquer C, Lehucher-Michel MP, Canal-Raffin M.
    Int J Hyg Environ Health. 2023
  6. Dual Orexin Receptor Antagonists and Suicide Risk: Findings From the WHO Spontaneous Reporting Database.
    Salvo F, Micoulaud-Franchi JA, Palagini L, Geoffroy PA.
    J Clin Psychiatry. 2023
  7. Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.
    Gouverneur A, Favary C, Jové J, Rouyer M, Bignon E, Salvo F, Tchalla A, Paillaud E, Aparicio T, Noize P.
    Target Oncol. 2023
  8. Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1 infected-patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study).
    Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43.
    Br J Clin Pharmacol. 2023
  9. Letter to the Editor: The Cannabinoid Consumed Is Not Necessarily the One Expected: Recent Experience with Hexahydrocannabinol.
    Guyon J, Paradis C, Titier K, Braganca C, Peyre A, Nardon A, Daveluy A, Molimard M, Labadie M, Castaing N.
    Cannabis Cannabinoid Res. 2023
  10. Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown.
    Perino J, Demourgues M, Ramaroson H, Bezin J, Micallef J, Miremont-Salamé G, Frauger E, Gilleron V, Ong N, Daveluy A.
    Public Health. 2023
  11. Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study.
    Maumus-Robert S, Jarne-Munoz A, Tournier M, Bégaud B, Pariente A.
    Drugs Aging. 2023
  12. Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims Database.
    Jambon-Barbara C, Bernardeau C, Bezin J, Roustit M, Blaise S, Cracowski JL, Khouri C.
    Drug Saf. 2023
  13. Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study.
    Allouchery M, Tomowiak C, Singier A, Puyade M, Dari L, Pambrun E, Pariente A, Bezin J, Pérault-Pochat MC, Salvo F.
    Br J Haematol. 2023
  14. Will the future of pharmacovigilance be more automated?
    Salvo F, Micallef J, Lahouegue A, Chouchana L, Létinier L, Faillie JL, Pariente A.
    Expert Opin Drug Saf. 2023
  15. Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study.
    Fusaroli M, Salvo F, Bernardeau C, Idris M, Dolladille C, Pariente A, Poluzzi E, Raschi E, Khouri C.
    Drug Saf. 2023
  16. [Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020]
    Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J.
    Therapie. 2023
  17. Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study.
    Tournier M, Bénard-Laribière A, Jollant F, Hucteau E, Diop PY, Jarne-Munoz A, Pariente A, Oger E, Bezin J.
    Acta Psychiatr Scand. 2023
  18. Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon.
    Mpoh MM, Deli V, Daniel TT, Salvo F.
    Int J Mycobacteriol. 2023
  19. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns.
    Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M.
    Int J Drug Policy. 2023
  20. Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted.
    Barraud D, Besançon L, Bik EM, Billy E, Clarot F, Frank F, Guihur A, Hajage D, Lacombe K, Maisonneuve H, Molimard M, Mulot M, Samuel A.
    Therapie. 2023